Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EuroapiXPAR:EAPI +1.75%54 FCF Margin % is 15.96% as of Dec. 2025. GuruFocus rates XPAR:EAPI with a GF Score™ of 54/100 and a GF Value™ of €2.88 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 963 Drug Manufacturers companies, Euroapi ranks better than 58.88% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Euroapi's Free Cash Flow for the
six
months ended in Dec. 2025 was €69.9 Mil. Euroapi's Revenue for the
six
months ended in Dec. 2025 was €438.1 Mil. Therefore, Euroapi's FCF Margin % for the quarter that ended in Dec. 2025 was 15.96%.
The historical rank and industry rank for Euroapi's FCF Margin % or its related term are showing as below:
XPAR:EAPI'
s FCF Margin % Range Over the Past 10 Years
Min: -12.53 Med: -1.92 Max: 5.86
Current: 5.86
During the past 7 years, the highest FCF Margin % of Euroapi was 5.86%. The lowest was -12.53%. And the median was -1.92%.
XPAR:EAPI's FCF Margin % is ranked better than 58.88% of 963
companies
in the Drug Manufacturers industry
Industry Median: 2.57
vs XPAR:EAPI: 5.86
Euroapi FCF Margin % Related Terms
Euroapi FCF Margin % Historical Data
* Premium members only.
The historical data trend for Euroapi's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:EAPI vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euroapi FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euroapi's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Euroapi's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euroapi (XPAR:EAPI) has a FCF Margin % of 15.96% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Euroapi and its competitors. According to the industry distribution chart, Euroapi ranks #396 out of 963 companies in the Drug Manufacturers industry, placing it in the top 41.1%.
Is Euroapi's FCF Margin % too high?
Euroapi's current FCF Margin % is 15.96%. The Drug Manufacturers industry median FCF Margin % is 2.57. Euroapi's value of 15.96% is 521% above this industry median. Based on the distribution chart, Euroapi ranks #396 out of 963 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Euroapi has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Euroapi's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euroapi ranks #396 out of 963 companies for FCF Margin %. This puts Euroapi in the upper half of its industry. The industry median FCF Margin % is 2.57. Euroapi's value of 15.96% is 521% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.57, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euroapi's current FCF Margin % of 15.96% is 521% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Euroapi and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euroapi's current FCF Margin % is 15.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euroapi stock overvalued right now?
Based on GuruFocus' analysis, Euroapi (XPAR:EAPI) is currently considered Possible Value Trap. The stock's GF Value™ is €2.88, compared to a current price of €1.28 — trading 55.6% below its estimated fair value. The current FCF Margin % is 15.96% and 521% above the Drug Manufacturers industry median of 2.57. Euroapi's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Euroapi (XPAR:EAPI), the current FCF Margin % is 15.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euroapi (XPAR:EAPI) Overvalued in 2026?
Based on GuruFocus' analysis, Euroapi stock appears to be undervalued.
The current stock price of €1.28 is trading 55.6% below its estimated GF Value™ of €2.88.
GuruFocus considers Euroapi to be Possible Value Trap.
Key valuation signals for XPAR:EAPI:
FCF Margin %: 15.96%
GF Value™: €2.88 vs. price of €1.28 (55.6% below fair value)
Industry Position: 521% above the Drug Manufacturers median (#396 of 963)
No single metric tells the full story. See the XPAR:EAPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
54GF Score
Get the complete analysis for XPAR:EAPI
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:EAPI has been successfully added to your 
